Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CAMP stock hub

Camp4 Therapeutics Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

CAMPis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
231.6M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
CAMP
In the news

Latest news · CAMP

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-209.3
P25 -105.6P50 -46.5P75 -3.1
ROIC-70.3
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All CAMP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
187
Groups with data
11
Currency
USD
Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0001736730
Company name
Camp4 Therapeutics Corporation
Country
United States
Country code
US
Cusip
13463J101
Employees
48
Employees Change
-7%
Employees Change Percent
-12.73
Enterprise value
$134.5M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
IPO Date
2024-10-11
Isin
US13463J1016
Last refreshed
2026-05-10
Market cap
$231.6M
Market cap category
Micro-Cap
Price
$4.46
Price currency
USD
Rev Per Employee
81,958.33x
Sector
Healthcare
Sic
2834
Symbol
CAMP
Website
https://www.camp4tx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-37.26%
EV Sales Forward
40.64x
EV/Sales
34.19x
FCF yield
-11.33%
P/B ratio
7.49x
P/S ratio
58.87x
PS Forward
69.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

9
MetricValue
Gross Profit
$-34.3M
Net Income
$-86.3M
Net Income Growth Years
0%
Pretax Margin
-2,193.72%
Profit Per Employee
$-1.8M
ROA
-38.66
ROCE
-58.57
ROE
-209.3
ROIC
-70.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr1y
103.75%
EPS Growth Quarters
1
EPS Growth Years
2
Revenue Growth
160.53x
Revenue Growth Q
50.82x
Revenue Growth Quarters
1x
Revenue Growth Years
2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Asset Turnover
$0.05
Assets
$105.5M
Cash
$99.2M
Current Assets
$102.2M
Current Liabilities
$16.6M
Debt
$2.1M
Debt Equity
$0.07
Equity
$30.9M
Liabilities
$74.6M
Long Term Assets
$3.3M
Long Term Liabilities
$57.9M
Net Cash
$97.1M
Net Cash By Market Cap
$41.92
Net Cash Growth
134.74%
Net Debt Equity
$-3.14
Tangible Book Value
$30.9M
Tangible Book Value Per Share
$0.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
6.15
Net Working Capital
$-13.3M
Quick ratio
5.97
Working Capital
$85.6M
Working Capital Turnover
$0.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-314.35%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
103.65%
200-day SMA
3.87
50-day SMA
4.62
50-day SMA vs 200-day SMA
50over200
All Time High
12.3
All Time High Change
-63.74%
All Time High Date
2024-10-14
All Time Low
1.31
All Time Low Change
241.76%
All Time Low Date
2025-06-20
ATR
0.39
Beta1y
1.55
Beta2y
1.73
Ch YTD
-27.24
High
4.5
High52
7.75
High52 Date
2026-03-09
High52ch
-42.45%
Low
4.09
Low52
1.31
Low52 Date
2025-06-20
Low52ch
241.76%
Ma50ch
-3.38%
Price vs 200-day SMA
15.13%
RSI
52.58
RSI Monthly
41.86
RSI Weekly
51.09
Sharpe ratio
1.12x
Sortino ratio
2.09
Total Return
-314.35%
Tr YTD
-27.24
Tr1m
-4.09%
Tr1w
10.12%
Tr3m
16.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

13
MetricValue
Analyst Count
6
Analyst Count Top
2
Analyst Price Target Top
$7
Analyst Ratings
Buy
Analyst Ratings Top
Buy
Earnings EPS Estimate
$-0.21
Earnings Revenue Estimate
1,226,400x
Earnings Revenue Estimate Growth
42.94x
Operating Income
$-52M
Operating margin
-1,322.6
Price target
$8.6
Price Target Change
$92.83
Price Target Change Top
$56.95

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
29,215,335%
Float Percent
56.26%
Net Borrowing
-57,000
Shares Insiders
1.47%
Shares Institutions
52.63%
Shares Out
51,925,800
Shares Qo Q
7.55%
Shares Yo Y
314.35%
Short Float
1.6%
Short Ratio
4.47
Short Shares
0.9

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
$-30.9M
Average Volume
69,354.05x
Bv Per Share
0.6
Ch1m
-4.09
Ch1w
10.12
Ch1y
103.7
Ch3m
16.15
Ch6m
4.94
Change
2.76%
Change From Open
5.69
Close
4.34
Days Gap
-2.76
Depreciation Amortization
1,738,000
Dollar Volume
158,981.2
Earnings Date
2026-05-07
Earnings Time
amc
EBIT
$-52M
EBITDA
$-50.3M
EPS
$-2.17
F Score
2
FCF
$-26.2M
FCF EV Yield
-19.51x
FCF Per Share
$-0.51
Financing CF
76,098,000
Fiscal Year End
December
Founded
2,016
Investing CF
36,000
Ipr
-59.45
Iprfo
-60.04
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Last Split Type
Never
Last10k Filing Date
2026-03-05
Ma150
4.5
Ma150ch
-0.8%
Ma20
4.35
Ma20ch
2.6%
Net CF
49,886,000
Next Earnings Date
2026-08-13
Open
4.22
Optionable
No
Position In Range
90.24
Post Close
4.46
Postmarket Change Percent
1.79
Postmarket Price
$4.54
Ppne
2,290,000
Price Date
2026-05-08
Ptbv Ratio
7.49
Relative Volume
0.51x
Revenue
3,934,000x
SBC By Revenue
117.16x
Share Based Comp
4,609,000
Tr6m
4.94%
Us State
Massachusetts
Volume
35,646
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does CAMP pay a dividend?

Capital-return profile for this ticker.

Performance

CAMP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+103.7%
S&P 500 1Y: n/a
3Y total return
n/a
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns CAMP?

Insider, institutional, and short-interest positioning.

Institutional ownership
+52.6%
Float: +56.3% of shares outstanding
Insider ownership
+1.5%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+1.6%
4.5 days to cover
Y/Y dilution
+314.3%
Negative means the company is buying back shares.
Technical

CAMP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
52.6
Neutral momentum band
Price vs 200-day MA
+15.1%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
1.12
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About CAMP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CAMP stock rating?

Camp4 Therapeutics Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CAMP analysis?

The full report lives at /stocks/CAMP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CAMP?

The latest report frames CAMP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CAMP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.